161 related articles for article (PubMed ID: 8399655)
1. Relationship between plasma beta 2-microglobulin and residual diuresis in continuous ambulatory peritoneal dialysis and hemodialysis patients.
Catizone L; Cocchi R; Fusaroli M; Zucchelli P
Perit Dial Int; 1993; 13 Suppl 2():S523-6. PubMed ID: 8399655
[TBL] [Abstract][Full Text] [Related]
2. Beta-2 microglobulin in patients on peritoneal dialysis and hemodialysis.
Scalamogna A; Imbasciati E; De Vecchi A; Castelnovo C; Pagliari B; De Cristofaro V; Ponticelli C
Perit Dial Int; 1989; 9(1):37-40. PubMed ID: 2488178
[TBL] [Abstract][Full Text] [Related]
3. Serum beta 2-microglobulin concentration in dialysis patients: importance of intrinsic renal function.
McCarthy JT; Williams AW; Johnson WJ
J Lab Clin Med; 1994 Apr; 123(4):495-505. PubMed ID: 8144998
[TBL] [Abstract][Full Text] [Related]
4. [Behavior of beta 2-microglobulin in patients undergoing blood purification].
Hou FF
Zhonghua Nei Ke Za Zhi; 1990 Jun; 29(6):353-6, 383. PubMed ID: 2269036
[TBL] [Abstract][Full Text] [Related]
5. [What does circulating beta 2 microglobulin signify in uremic patients on maintenance dialysis?].
Assounga A; Canaud B; Flavier JL; Slingeneyer A; Robinet-Lévy M; Aznar R; Mion C
Nephrologie; 1987; 8(6):301-6. PubMed ID: 3330579
[TBL] [Abstract][Full Text] [Related]
6. Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose.
Heimbürger O; Stenvinkel P; Berglund L; Tranoeus A; Lindholm B
Nephron; 1996; 72(2):135-44. PubMed ID: 8684516
[TBL] [Abstract][Full Text] [Related]
7. Continuous ambulatory peritoneal dialysis vs haemodialysis: a lesser risk of amyloidosis?
Tielemans C; Dratwa M; Bergmann P; Goldman M; Flamion B; Collart F; Wens R
Nephrol Dial Transplant; 1988; 3(3):291-4. PubMed ID: 3140103
[TBL] [Abstract][Full Text] [Related]
8. Beta 2-microglobulin elimination in end-stage renal disease patients on renal replacement therapy.
Stefanović V; Kostić S; Djordjević V; Mitić M; Bogicević M
Perit Dial Int; 1993; 13 Suppl 2():S520-2. PubMed ID: 8399654
[TBL] [Abstract][Full Text] [Related]
9. Dialysis-related amyloidosis in a large CAPD population.
Catizone L; Viglietta G; Cocchi R; Dadone C; De Vecchi A; Giangrande A; Lindner G; Manili L; Querques M; Ramello A
Adv Perit Dial; 1995; 11():213-7. PubMed ID: 8534708
[TBL] [Abstract][Full Text] [Related]
10. Preservation of residual renal function in dialysis patients: effects of dialysis-technique-related factors.
Lang SM; Bergner A; Töpfer M; Schiffl H
Perit Dial Int; 2001; 21(1):52-7. PubMed ID: 11280496
[TBL] [Abstract][Full Text] [Related]
11. Beta 2-microglobulin levels in patients with renal insufficiency.
Acchiardo S; Kraus AP; Jennings BR
Am J Kidney Dis; 1989 Jan; 13(1):70-4. PubMed ID: 2643313
[TBL] [Abstract][Full Text] [Related]
12. Evidence for preservation of cortical bone mineral density in patients on continuous ambulatory peritoneal dialysis.
Mottet JJ; Horber FF; Casez JP; Descoeudres C; Jaeger P
J Bone Miner Res; 1996 Jan; 11(1):96-104. PubMed ID: 8770702
[TBL] [Abstract][Full Text] [Related]
13. Beta-2 microglobulin serum levels in maintenance dialysis. What does it mean?
Canaud B; Assounga A; Flavier JL; Slingeneyer A; Aznar R; Robinet-Levy M; Mion C
ASAIO Trans; 1988; 34(4):923-9. PubMed ID: 3064791
[TBL] [Abstract][Full Text] [Related]
14. Endothelin-1 in continuous ambulatory peritoneal dialysis and hemodialysis patients: a preliminary study.
Lightfoot BO; Caruana RJ
Perit Dial Int; 1993; 13(1):55-8. PubMed ID: 8443279
[TBL] [Abstract][Full Text] [Related]
15. Influence of CAPD and residual diuresis on the serum levels of alpha-1-microglobulin in end-stage renal disease.
Weber MH; Reetze P; Neumann F; Warneke G; Scheler F
Nephron; 1989; 51(3):367-9. PubMed ID: 2465498
[TBL] [Abstract][Full Text] [Related]
16. A study of beta 2-microglobulin skin deposits in dialyzed patients and healthy controls.
Assounga AG; Bascoul S; Canaud B; Bouya PA; Vendrell JP; Sciolla JP; Mourad G; Baldet P; Serre A; Mion C
Am J Kidney Dis; 1990 Jun; 15(6):556-61. PubMed ID: 2195873
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory effects of peritoneal dialysis: evidence of systemic monocyte activation.
Libetta C; De Nicola L; Rampino T; De Simone W; Memoli B
Kidney Int; 1996 Feb; 49(2):506-11. PubMed ID: 8821837
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W
Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852
[TBL] [Abstract][Full Text] [Related]
19. Plasma myeloperoxidase, NT-proBNP, and troponin-I in patients on CAPD compared with those on regular hemodialysis.
Al-Hweish A; Sultan SS; Mogazi K; Elsammak MY
Hemodial Int; 2010 Jul; 14(3):308-15. PubMed ID: 20597992
[TBL] [Abstract][Full Text] [Related]
20. [Serum beta 2-microglobulin concentration and its removal in patients treated with continuous ambulatory peritoneal dialysis].
Kubo H; Kawaguchi Y; Aizawa S; Morita T; Nakayama M; Wakabayashi Y; Watanabe S; Ogawa A; Sakai O
Nihon Jinzo Gakkai Shi; 1990 Apr; 32(4):419-26. PubMed ID: 2198365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
